Dendreon
Get Full AccessDescription
- Dendreon Corporation is a biotechnology company targeting cancer and transforming lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first autologous cellular immunotherapy product, PROVENGE(R) (sipuleucel-T), was approved by the FDA in April 2010 for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer. Dendreon also is developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer. The Company is headquartered in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/
-
Headquarters:1700 Saturn Way , Seal Beach, California, United States
More -
Phone Number: +1 206-256-4541
-
Website: https://www.dendreon.com
-
Employees:656
-
Revenue:$500M - 1B
-
Legal Name:Dendreon
-
Dendreon's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Dendreon
-
Where are Dendreon's Headquarters?
Dendreon's Headquarters are in 1700 Saturn Way ,Seal Beach,California,United States
-
What is Dendreon's phone number?
Dendreon's phone number is +1 206-256-4541
-
What is Dendreon's official website?
Dendreon's official website is https://www.dendreon.com
-
What is Dendreon's Revenue?
Dendreon's revenue is $500M - 1B
-
What is Dendreon's NAICS code?
Dendreon's NAICS code is 325412
-
How many employees are working in Dendreon
Dendreon has 656 employees
-
What is Dendreon's Industry?
Dendreon is in the industry of Biotechnology
-
Who is Dendreon's CEO?
Dendreon's CEO is Jason O'neill

